Home › Research › Tau biomarkers
Neurocytoskeleton Proteins in Cerebrospinal Fluid of People With HIV-1 Subtypes B and C
de Almeida SM, Ribeiro CE, Tang B, de Pereira AP, Rotta I, Vaida F, Letendre S, Potter M et al.. Journal of acquired immune deficiency syndromes (1999), 2020-08-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
Background The objective was to compare the effect of HIV-1C and HIV-1B subtypes on neurofilament light (NfL) cerebrospinal fluid (CSF) levels and ratios of NfL to tau proteins. Additional comparisons were performed between people with HIV (PWH), participants with Alzheimer disease (AD), and HIV-negative controls (HIV-). We also calculated the diagnostic characteristics of CSF NfL and its ratios in HIV-associated neurocognitive disorder (HAND) diagnosis.
What this study adds
Evidence grade: Low
The record lists 68 participants. This study compared cerebrospinal fluid nerve cytoskeleton proteins in people with HIV subtypes B and C, people with Alzheimer's disease, and HIV-negative controls. Reported effect size: 53.85%; 29.63%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
de Almeida, S. M., Ribeiro, C. E., Tang, B., de Pereira, A. P., Rotta, I., Vaida, F., et al. (2020). Neurocytoskeleton Proteins in Cerebrospinal Fluid of People With HIV-1 Subtypes B and C. Journal of acquired immune deficiency syndromes (1999). https://doi.org/10.1097/qai.0000000000002389
Vancouver
de Almeida SM, Ribeiro CE, Tang B, de Pereira AP, Rotta I, Vaida F, et al. Neurocytoskeleton Proteins in Cerebrospinal Fluid of People With HIV-1 Subtypes B and C. Journal of acquired immune deficiency syndromes (1999). 2020. doi:10.1097/qai.0000000000002389. PMID: 32692110.
BibTeX
@article{dealmeida2020-32692110,
author = {de Almeida, S. M. and Ribeiro, C. E. and Tang, B. and de Pereira, A. P. and Rotta, I. and Vaida, F. and Letendre, S. and Potter, M. and others},
title = {{Neurocytoskeleton Proteins in Cerebrospinal Fluid of People With HIV-1 Subtypes B and C}},
journal = {Journal of acquired immune deficiency syndromes (1999)},
year = {2020},
doi = {10.1097/qai.0000000000002389},
pmid = {32692110},
url = {https://doi.org/10.1097/qai.0000000000002389}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Additional comparisons were performed between people with HIV (PWH), participants with Alzheimer disease (AD), and HIV-negative controls (HIV-).
- We also calculated the diagnostic characteristics of CSF NfL and its ratios in HIV-associated neurocognitive disorder (HAND) diagnosis.
- Methods CSF NfL, T-tau, and P-tau181 concentrations were measured using immunoassays in a total of 108 CSF samples, including PWH (n = 68), HIV- (n = 16), and participants with AD (n = 24).
- These proteins were compared between HIV-1B (n = 27) and HIV-1C (n = 26) using multiple linear regression adjusted for nadir CD4 and plasma viral load suppression.
Why it matters
This study compared cerebrospinal fluid nerve cytoskeleton proteins in people with HIV subtypes B and C, people with Alzheimer's disease, and HIV-negative controls. It is about biomarkers in HIV-related cognitive disorder, not about treating, curing or preventing Alzheimer's disease.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants68
- Effect size53.85%; 29.63%
- Evidence strengthLow
How this study scored 41/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it. We have no data on journal's citation record, so that was left out: it earned 39 of the 96 points we could judge it on, which is 41 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of acquired immune deficiency syndromes (1999)) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 1 / 4 | 68 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 5 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.6 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 1 / 6 | Cited 0.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Ronald J. Ellis: h-index 86 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of California San Diego: institution h-index 1,852 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 32692110) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 39 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 39 of the 96 points we could judge it on is 41 out of 100. |
| Total | 41 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1097/qai.0000000000002389
- PubMed: 32692110
- Original source →
- Free full text: PubMed Central →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.